SC Engineering Co., Ltd engages primarily in the manufacturing, selling, importing, and exporting of biological products and medical devices using cell culture technologies. Its core product portfolio includes biological products and medical devices, with a focus on cell culture applications. The company also designs and manufactures chemical plant facilities, sells hydraulic equipment, and air-cooled heat exchangers. SC Engineering operates within the industrial machinery and equipment sector, serving markets in South Korea and internationally. Founded in 1990 and headquartered in Ulsan, South Korea, the company has expanded its capabilities in engineering and manufacturing related to biotechnology and industrial equipment.
In recent developments, SC Engineering has entered into a letter of intent to acquire a 51% stake in Cellontech Co., Ltd. for KRW 17.136 billion, signaling a strategic expansion into specialized biotechnology and cell culture-related products. This move aligns with its focus on growing the biological products segment. The company reported solid revenue growth of 11% for the past year and sustained a 39% increase over the last three years, reflecting robust operational performance. The acquisition of Cellontech also positions SC Engineering to enhance its competitive profile in the biotech industry.
SC Engineering's operations span manufacturing biological and medical devices, chemical plant facility construction, hydraulic equipment sales, and heat exchanger production. These product lines target medical, industrial, and chemical sectors primarily within South Korea but with international reach. The company continues to leverage engineering expertise and product innovation to expand its market presence while pursuing strategic acquisitions to diversify and strengthen its product offerings. SC Engineering remains headquartered in Ulsan, South Korea, with a legacy dating back to its founding in 1990.